” ??????????????????????????FDA?

2008年11月13日(木)

投稿者: ????????

??FDA?????10?????????????????????????????????????Early Communication?????????????????????????????????????????????????12?????????????????????

Update of Safety Review Follow-up to the October 1, 2007
Early Communication about the Ongoing Safety Review of Bisphosphonates
???FDA?2008.11.12?
?http://www.fda.gov/cder/drug/early_comm/bisphosphonates_update_200811.htm

??????????NEJM ???????????????????????FDA??38,000?????19,687???????18,358????????????????????

?FDA???????????????????????????????????????????????????????????????????????????????????????????????????

????????????????????????????????????????????????????

??Early Communication of an Ongoing Safety Review?FDA?
????http://www.fda.gov/cder/drug/early_comm/bisphosphonates.htm
?????????????????????Vol.5 No.21 ???
?????http://www.nihs.go.jp/dig/sireport/weekly5/21071018.pdf
??Alendronate and Atrial Fibrillation?NEJM 356: 1895-1896?
????http://content.nejm.org/cgi/content/extract/356/18/1895
????????????????????
??Information on Bisphosphonates?FDA 2008.1.7?
????http://www.fda.gov/cder/drug/infopage/bisphosphonates/default.htm

12?26??????

この記事にはまだコメントがついていません。

現在、この記事へのコメントは頂いておりません。